20170347

Hamurcu Z

2010

Micronucleus frequency in lymphocytes and 8-hydroxydeoxyguanosine level in plasma of women with polycystic ovary syndrome.

20170349

Takikawa S

2010

Assessment of the predictive value of follicular fluid insulin, leptin and adiponectin in assisted reproductive cycles.

20170352

Draveck? I

2010

The prevalence of Gly972Arg and C825T polymorphisms in Slovak women with polycystic ovary syndrome and their relation to the metabolic syndrome.

20171617

Verit FF

2010

Re: Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women.

20171618

Naessen T

2010

Steroid profiles in ovarian follicular fluid in women with and without polycystic ovary syndrome, analyzed by liquid chromatography-tandem mass spectrometry.

20172866

Stoop D

2010

Offering excess oocyte aspiration and vitrification to patients undergoing stimulated artificial insemination cycles can reduce the multiple pregnancy risk and accumulate oocytes for later use.

20172872

Chen X

2010

Appropriate BMI levels for PCOS patients in Southern China.

20175706

Kuivasaari-Pirinen P

2010

Cumulative baby take-home rate among women with PCOS treated by IVF.

20178540

Zhu R

2010

Aberrantly increased mRNA expression of betaglycan, an inhibin co-receptor in the ovarian tissues in women with polycystic ovary syndrome.

20180027

Oride A

2010

Effects of metformin administration on plasma gonadotropin levels in women with infertility, with an in vitro study of the direct effects on the pituitary gonadotrophs.

20182736

Kim YJ

2010

A comparative study on the outcomes of in vitro fertilization between women with polycystic ovary syndrome and those with sonographic polycystic ovary-only in GnRH antagonist cycles.

20185255

Mascitelli L

2010

Body iron stores and gender differences in risk factors for coronary heart disease.

20185515

Fan P

2010

Identification of the G994T polymorphism in exon 9 of plasma platelet-activating factor acetylhydrolase gene as a risk factor for polycystic ovary syndrome.

20186113

Artini PG

2010

Best methods for identification and treatment of PCOS.

20186511

Li C

2010

Efficient derivation of Chinese human embryonic stem cell lines from frozen embryos.

20187731

Moran LJ

2010

Polycystic ovary syndrome and weight management.

20188364

Aboulghar M

2010

Prospective, randomized study comparing highly purified urinary follicle-stimulating hormone (FSH) and recombinant FSH for in vitro fertilization/intracytoplasmic sperm injection in patients with polycystic ovary syndrome.

20188831

Motta AB

2010

Dehydroepiandrosterone to induce murine models for the study of polycystic ovary syndrome.

20189560

Trolle B

2010

Adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a randomized controlled study.

20189706

Vural P

2010

Tumor necrosis factor alpha (-308), interleukin-6 (-174) and interleukin-10 (-1082) gene polymorphisms in polycystic ovary syndrome.

20190263

Landres IV

2010

Karyotype of miscarriages in relation to maternal weight.

20190557

Tong D

2010

The relationship between CAG repeat length polymorphism and infertility in Southern Chinese Han women.

20191835

Socolov R

2009

[Clinical and paraclinical diagnosis of pelvic endometriosis. Clinical study].

20193420

Wang PY

2009

[Clinical study on in vitro maturation of immature oocytes transferred from conventional in vitro fertilization.].

20195177

Stachenfeld NS

2010

Greater exercise sweating in obese women with polycystic ovary syndrome compared with obese controls.

20197671

Saranac L

2010

Hyperprolactinemia: different clinical expression in childhood.

20199774

El-Mazny A

2010

Insulin resistance, dyslipidemia, and metabolic syndrome in women with polycystic ovary syndrome.

20200332

Ewens KG

2010

Family-based analysis of candidate genes for polycystic ovary syndrome.

20201644

Pucci L

2010

Lack of association between CYP21 V281L variant and polycystic ovary syndrome in Italian women.

20206433

Kaya C

2010

An increase in systolic blood pressure and abnormal circadian blood pressure regulation in lean women with polycystic ovary syndrome.

20207341

Huddleston HG

2010

Racial and ethnic disparities in reproductive endocrinology and infertility.

20207350

Wang L

2010

Common genetic variation in MTNR1B is associated with serum testosterone, glucose tolerance, and insulin secretion in polycystic ovary syndrome patients.

20207725

Pellatt L

2010

Anti-M?llerian hormone and polycystic ovary syndrome: a mountain too high?

20209851

Kdous M

2009

[Increased risk of early pregnancy loss and lower live birth rate with GNRH antagonist vs. long GNRH agonist protocol in PCOS women undergoing controlled ovarian hyperstimulation].

20210696

Christopoulos P

2010

Study of association of IRS-1 and IRS-2 genes polymorphisms with clinical and metabolic features in women with polycystic ovary syndrome. Is there an impact?

20218821

Farhi J

2010

The association between follicular size on human chorionic gonadotropin day and pregnancy rate in clomiphene citrate treated polycystic ovary syndrome patients.

20222834

Villarroel C

2010

Assessment of diagnostic competence of plasmatic androgens on polycystic ovary syndrome based on receiver operator characteristic curves.

20222840

Raffone E

2010

Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women.

20228162

Anderson H

2010

Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels.

20229450

Pappalardo MA

2010

Very high frequency of the polymorphism for the insulin receptor substrate 1 (IRS-1) at codon 972 (glycine972arginine) in Southern Italian women with polycystic ovary syndrome.

20230329

Lim CE

2010

Current evidence of acupuncture on polycystic ovarian syndrome.

20230548

Malik-Aslam A

2010

The suitability of polycystic ovary syndrome-specific questionnaires for measuring the impact of PCOS on quality of life in clinical trials.

20231113

Segal S

2010

Serum inhibin A concentration in women with polycystic ovarian syndrome and the correlation to ethnicity, androgens and insulin resistance.

20236105

Sproul K

2010

Association study of four key folliculogenesis genes in polycystic ovary syndrome.

20236107

Palomba S

2010

Uterine blood flow in pregnant patients with polycystic ovary syndrome: relationships with clinical outcomes.

20236632

Matteo M

2010

Reduced percentage of natural killer cells associated with impaired cytokine network in the secretory endometrium of infertile women with polycystic ovary syndrome.

20300436

Peppa M

2010

Skeletal muscle insulin resistance in endocrine disease.

20303485

Guastella E

2010

Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes.

20303643

Tay J

2010

Isolated torsion of the fallopian tube in a patient with polycystic ovarian syndrome (PCOS).

20307398

Masharani U

2010

Effects of controlled-release alpha lipoic acid in lean, nondiabetic patients with polycystic ovary syndrome.

20308754

Champagne KA

2010

Sleep disordered breathing in women of childbearing age & during pregnancy.

20329610

Zhang WY

2009

[Influences of acupuncture on infertility of rats with polycystic ovarian syndrome].

20332077

Langm?r Z

2010

[Diagnosis and treatment of polycystic ovary syndrome].

20332127

Ganie MA

2010

High prevalence of polycystic ovary syndrome characteristics in girls with euthyroid chronic lymphocytic thyroiditis: a case-control study.

20334584

Lenarcik A

2010

The role of chronic inflammation and Leu55Met PON1 polymorphism in the pathogenesis of polycystic ovary syndrome.

20337206

Zeinalzadeh M

2010

Efficacy of letrozole in ovulation induction compared to that of clomiphene citrate in patients with polycystic ovarian syndrome.

20338557

Wiltgen D

2010

Variation in metabolic and cardiovascular risk in women with different polycystic ovary syndrome phenotypes.

20339367

Knudsen KL

2010

Hyperandrogenemia in obese peripubertal girls: correlates and potential etiological determinants.

20350267

Salameh BS

2010

Metabolic and nutritional changes after bariatric surgery.

20350288

Pellegrino M

2010

WNT4 signaling in female gonadal development.

20350839

Stener-Victorin E

2010

Effects and mechanisms of acupuncture in the reproductive system.

20356579

Pelletier L

2010

Clinically significant and sustained weight loss is achievable in obese women with polycystic ovary syndrome followed in a regular medical practice.

20356587

Had?iomerovi?-Peki? D

2010

Metformin, naltrexone, or the combination of prednisolone and antiandrogenic oral contraceptives as first-line therapy in hyperinsulinemic women with polycystic ovary syndrome.

20356900

de Niet JE

2010

Psychological well-being and sexarche in women with polycystic ovary syndrome.

20356934

Chiavaroli V

2010

GNRH analog therapy in girls with early puberty is associated with the achievement of predicted final height but also with increased risk of polycystic ovary syndrome.

20359725

Wickham EP 3rd

2011

Total and high-molecular weight adiponectin in women with the polycystic ovary syndrome.

20360612

Be?towski J

2010

Liver X receptor (LXR) and the reproductive system--a potential novel target for therapeutic intervention.

20362961

van Houten EL

2010

Anti-M?llerian hormone (AMH): regulator and marker of ovarian function.

20362964

Vigouroux C

2010

What have we learned form monogenic forms of severe insulin resistance associated with PCOS/HAIRAN?

20362969

Franks S

2010

Aberrant follicle development and anovulation in polycystic ovary syndrome.

20367923

Wan DH

2010

[Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance].

20368201

Cheang KI

2009

Long-term effect of metformin on metabolic parameters in the polycystic ovary syndrome.

20371657

Alemzadeh R

2010

Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome.

20375205

Wild RA

2010

Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.

20377810

Miller M

2010

Managing mixed dyslipidemia in special populations.

20378107

Hudecova M

2010

Endothelial function in patients with polycystic ovary syndrome: a long-term follow-up study.

20378617

Qu F

2010

Altered aquaporin expression in women with polycystic ovary syndrome: hyperandrogenism in follicular fluid inhibits aquaporin-9 in granulosa cells through the phosphatidylinositol 3-kinase pathway.

20379731

Tehraninejad ES

2010

Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOs patients.

20381789

Dewailly D

2010

Which morphological investigations and how to interpret them to make the diagnosis of PCOS?

20381953

Lujan ME

2010

Grid analysis improves reliability in follicle counts made by ultrasonography in women with polycystic ovary syndrome.

20385380

Moran LJ

2010

The effect of modifying dietary protein and carbohydrate in weight loss on arterial compliance and postprandial lipidemia in overweight women with polycystic ovary syndrome.

20388053

Demirci H

2010

Frequency of adiponectin gene polymorphisms in polycystic ovary syndrome and the association with serum adiponectin, androgen levels, insulin resistance and clinical parameters.

20394912

Bouchard P

2010

Treatment of infertility in women with polycystic ovary syndrome.

20395229

Makedos A

2010

Serum high-sensitivity C-reactive protein and homocysteine changes during hormonal therapy in women with polycystic ovary syndrome: a prospective, matched study.

20395425

Brewer CJ

2010

The adverse effects of obesity on conception and implantation.

20396356

Hu WH

2010

[Clinical features of the metabolic syndrome in patients with polycystic ovary syndrome].

20396393

Sathyapalan T

2010

Mediators of inflammation in polycystic ovary syndrome in relation to adiposity.

20399696

Du J

2010

Two FSHR variants, haplotypes and meta-analysis in Chinese women with premature ovarian failure and polycystic ovary syndrome.

20406678

Jana SK

2010

Upper control limit of reactive oxygen species in follicular fluid beyond which viable embryo formation is not favorable.

20406953

Kohan K

2010

Role of the transcriptional factors FOXO1 and PPARG on gene expression of SLC2A4 in endometrial tissue from women with polycystic ovary syndrome.

20409101

Benson S

2010

Maladaptive coping with illness in women with polycystic ovary syndrome.

20409535

Young J

2010

[Editorial: ovarian physiology].

20410226

Roelfsema F

2010

Cortisol production rate is similarly elevated in obese women with or without the polycystic ovary syndrome.

20413084

Fulghesu A

2010

Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome.

20413367

Fern?ndez M

2010

Neonatal exposure to bisphenol a and reproductive and endocrine alterations resembling the polycystic ovarian syndrome in adult rats.

20415186

Khrouf M

2010

[Clinicals and biological aspects of ICSI cycles on patients with polycystic ovary syndrome].

20420718

Priyadarshani A

2010

Radiolabeling, biodistribution and gamma scintigraphy of noscapine hydrochloride in normal and polycystic ovary induced rats.

20426491

Choi DH

2010

The apolipoprotein A-I level is downregulated in the granulosa cells of patients with polycystic ovary syndrome and affects steroidogenesis.

20427499

Chen MJ

2010

Hyperandrogenemia is independently associated with elevated alanine aminotransferase activity in young women with polycystic ovary syndrome.

20427759

Arck P

2010

Nuclear receptors of the peroxisome proliferator-activated receptor (PPAR) family in gestational diabetes: from animal models to clinical trials.